Premium Information is available for this item - Upgrade for $1 a day
6505-00-200-1576
Usp Warfarin Sodium Tablets
6505002001576 002001576 2045
INC: 27974 Warfarin Sodium Tablets
November 2023
7

Marketplace 6505-00-200-1576
Request a Quotation from participating marketplace vendors






Related Documents 6505-00-200-1576 5+ Documents (More...)
Sodium Tablets 6505002001576 Vendor Details ... 2045 WARFARIN SODIUM TABLETS https/ /www.nsnlookup.com
Usp Warfarin Sodium Tablets 6505002001576 to View Vendor Details... 2045 WARFARIN SODIUM TABLETS
Usp Warfarin Sodium Tablets 6505002001576 6505002001576 Warfarin Sodium Tablets 6505002001576 https
Warfarin Sodium Tablets 6505218461990 /www.nsnlookup.com Sodium Tablets 6505218461990 https 6505/us 6505-00-200-1576
Usp Warfarin Sodium Tablets 6505002001576 to View Vendor Details... 2045 WARFARIN SODIUM TABLETS
,USP 86 EA NS Request Quotation 2045 WARFARIN Sodium Tablets 6505002001576 Warfarin Sodium Tablets 6505002001576
Usp Warfarin Sodium Tablets 6505002001576 6505002001576 6505190020623 NATO Warfarin Sodium Tablets
Sodium Tablets 6505009657566 https 6505009657566 https//www.nsnlookup.com /fsg https Sodium Tablets 6505002001576
Usp Warfarin Sodium Tablets 6505002001576 6505007282617 https https Sodium Tablets 6505002001576
Restrictions 6505-00-200-1576
6505-00-200-1576 is a Usp Warfarin Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-00-200-1576
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-200-1576
- Part Number
- Manufacturer
- Status
- 2045
- Manufacturer
- 04490 - Bristol-Myers Squibb Pharma Company (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-00-200-1576
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 2.000 Milligrams Warfarin Sodium Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 1000.000 Tablets
Similar Supply Items to 6505-00-200-1576


















Freight Information 6505-00-200-1576
6505-00-200-1576 has freight characteristics.. 6505-00-200-1576 has a variance between NMFC and UFC when transported by rail and the description should be consulted.